COVID-19-associated myocardial injury: A case report

ESC Heart Fail. 2023 Apr;10(2):1461-1466. doi: 10.1002/ehf2.14295. Epub 2023 Jan 24.

Abstract

Coronavirus disease 2019 (COVID-19) is often accompanied by pneumonia and can be fatal. We report a case of COVID-19-associated myocardial injury mimicking fulminant myocarditis. Endomyocardial biopsy revealed numerous von Willebrand factor-rich microthrombi with small myocardial necrotic areas, complement deposits in small vessels/microthrombi, and macrophage-predominant interstitial infiltration. These findings, distinct from those of typical lymphocytic myocarditis, show diffuse endothelial injury, complement activation, and activated macrophages as characteristic features of COVID-19-associated pathogenesis. Dysregulated serum cytokine profiles predicting severe/critical COVID-19-associated myocardial injury were also determined. This case emphasizes the occurrence of fatal cardiac manifestation with microthrombotic injury in the early stage of COVID-19.

Keywords: COVID-19; Complement; Endothelial injury; Macrophage infiltration; Microthrombi; Myocardial injury.

Publication types

  • Case Reports

MeSH terms

  • COVID-19* / complications
  • Heart
  • Humans
  • Myocardial Infarction*
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology
  • SARS-CoV-2